We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-4.48%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$387B
AUM Growth
-$17.5B
Cap. Flow
-$6.97B
Cap. Flow %
-1.8%
Top 10 Hldgs %
31.87%
Holding
14,936
New
2,168
Increased
5,454
Reduced
5,273
Closed
1,852

Sector Composition

Rank Sector Weight
1 Technology 1.87%
2 Consumer Discretionary 1.66%
3 Communication Services 1.09%
4 Financials 1.07%
5 Energy 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAXJ icon
12976
PUT
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.87B
-70,400
Closed -$4.87M
ABCB icon
12977
PUT
Ameris Bancorp
ABCB
$5.74B
-5,400
Closed -$217K
ABTS icon
12978
PUT
Abits Group
ABTS
$4.31M
-827
Closed -$12K
ACCO icon
12979
CALL
Acco Brands
ACCO
$389M
-28,000
Closed -$183K
ACEL icon
12980
CALL
Accel Entertainment
ACEL
$966M
-16,500
Closed -$175K
ACHV icon
12981
CALL
Achieve Life Sciences
ACHV
$841M
-15,200
Closed -$74K
ACIU icon
12982
AC Immune
ACIU
$290M
-16,546
Closed -$52.1K
ACNB icon
12983
ACNB Corp
ACNB
$658M
-32,562
Closed -$967K
ACRS icon
12984
CALL
Aclaris Therapeutics
ACRS
$962M
-12,600
Closed -$176K
ADAP
12985
DELISTED
Adaptimmune Therapeutics
ADAP
-134,912
Closed -$229K
ADAP
12986
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
-37,400
Closed -$64K
ZNB
12987
Zeta Network Group
ZNB
$1.7M
0
-$4K
ADIL
12988
Adial Pharmaceuticals
ADIL
$15.3M
-159
Closed -$133K
ADN
12989
DELISTED
Advent Technologies
ADN
-7,575
Closed -$675K
ADTX
12990
DELISTED
ADITXT INC
ADTX
0
ADVM
12991
DELISTED
Adverum Biotechnologies
ADVM
-9,489
Closed -$125K
AENTW icon
12992
Alliance Entertainment Holding Corp Warrants
AENTW
$3.65M
-16,635
Closed -$3K
AEVA
12993
CALL
Aeva Technologies
AEVA
$1.13B
-2,360
Closed -$37K
AEYE icon
12994
CALL
AudioEye
AEYE
$92.6M
-28,700
Closed -$172K
AFG icon
12995
American Financial Group
AFG
$11.9B
-27,047
Closed -$3.55M
AFIF icon
12996
Anfield Universal Fixed Income ETF
AFIF
$228M
-14,129
Closed -$125K
AFRM icon
12997
Affirm
AFRM
$26.1B
-254,404
Closed -$6.65M
RYM
12998
RYTHM Inc
RYM
$51.2M
-8
Closed -$27.2K
RYM
12999
PUT
RYTHM Inc
RYM
$51.2M
-12
Closed -$71K
AGL icon
13000
Agilon Health
AGL
$1.61B
-1,242
Closed -$744K

Similar funds

Jeff Yass's Q3 2022 Portfolio in Review

As of Q3 2022, Jeff Yass held 14,936 positions worth $387B, down 4.3% from $404B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2022 filing shows 2,168 new, 5,454 increased, 5,273 reduced and 1,852 closed positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M. The largest sale was Tesla, an estimated $799M.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, up from 1.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Jeff Yass's largest Q3 2022 buy was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M.
  • Jeff Yass added most to Amazon in Q3 2022, an estimated $1.21B increase.
  • Jeff Yass's biggest Q3 2022 reduction was Tesla, cutting an estimated $799M.
  • Jeff Yass fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $151M.
  • Jeff Yass's ten largest holdings make up 32% of its $387B portfolio in Q3 2022.
  • Jeff Yass opened 2,168 new positions and closed 1,852 in Q3 2022.
  • Jeff Yass's portfolio value fell 4.3% quarter-over-quarter to $387B.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.